Treatment of patients with adult T cell leukemia/lymphoma with cord blood transplantation: A japanese nationwide retrospective survey

Biology of Blood and Marrow Transplantation

Volumn 20, Issue 12, 2014, Pages 1968-1974

  Kato, Koji ^a,k   Choi, Ilseung ^b   Wake, Atsushi ^c   Uike, Naokuni ^b   Taniguchi, Shuichi ^c   Moriuchi, Yukiyoshi ^d   Miyazaki, Yasushi ^e   Nakamae, Hirohisa ^f   Oku, Eijirou ^g   Murata, Makoto ^h   Eto, Tetsuya ⁱ   Akashi, Koichi ^a   Sakamaki, Hisashi ^j   Suzuki, Ritsuro ^h   Yamanaka, Takeharu ^l   Utsunomiya, Atae ^m  

^a KYUSHU UNIVERSITY   (Japan)

^b NATIONAL KYUSHU CANCER CENTER   (Japan)

^c TORANOMON HOSPITAL   (Japan)

^d Sasebo Shiritsu Sogo Hospital   (Japan)

^e NAGASAKI UNIVERSITY GRADUATE SCHOOL OF BIOMEDICAL SCIENCES   (Japan)

^f OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^g Kurume University Graduate School of Medicine Kurume University Graduate School of Medicine Graduate School Biostatistics   (Japan)

^h NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

ⁱ HAMANOMACHI HOSPITAL   (Japan)

^j TOKYO METROPOLITAN KOMAGOME HOSPITAL   (Japan)

^k JAPANESE RED CROSS NAGOYA FIRST HOSPITAL   (Japan)

^l NATIONAL CANCER CENTER HOSPITAL EAST   (Japan)

^m Imamura Bun in Hospital   (Japan)

more..

Author keywords

Adult T cell leukemia lymphoma (ATTL); Cord blood transplantation; Graft versus adult T cell leukemia lymphoma

Indexed keywords

BUSULFAN; CYCLOSPORIN; FLUDARABINE; MELPHALAN; METHOTREXATE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISOLONE; TACROLIMUS;

ADULT; AGED; ARTICLE; CANCER MORTALITY; CANCER SURVIVAL; CHRONIC GRAFT VERSUS HOST DISEASE; CORD BLOOD STEM CELL TRANSPLANTATION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; REDUCED INTENSITY CONDITIONING; RETROSPECTIVE STUDY; T CELL LEUKEMIA; WHOLE BODY RADIATION; ACUTE DISEASE; ALLOGRAFT; BONE MARROW TRANSPLANTATION; CLINICAL TRIAL; DISEASE FREE SURVIVAL; EPIDEMIOLOGY; GRAFT VERSUS LEUKEMIA EFFECT; GRAFT VS HOST DISEASE; JAPAN; LEUKEMIA-LYMPHOMA, ADULT T-CELL; MIDDLE AGED; MORTALITY; MULTICENTER STUDY; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; SURVIVAL RATE;

ACUTE DISEASE; ADULT; AGED; ALLOGRAFTS; BONE MARROW TRANSPLANTATION; CORD BLOOD STEM CELL TRANSPLANTATION; DISEASE-FREE SURVIVAL; FEMALE; GRAFT VS HOST DISEASE; GRAFT VS LEUKEMIA EFFECT; HUMANS; JAPAN; LEUKEMIA-LYMPHOMA, ADULT T-CELL; MALE; MIDDLE AGED; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; RETROSPECTIVE STUDIES; SURVIVAL RATE;

EID: 84912120970     PISSN: 10838791     EISSN: 15236536     Source Type: Journal    
DOI: 10.1016/j.bbmt.2014.08.012     Document Type: Article

References (39)

1. Uchiyama T., Yodoi J., Sagawa K., et al. Adult T-cell leukemia: clinical and hematologic features of 16 cases. Blood 1977, 50:481-492.
2. Tsukasaki K., Maeda T., Arimura K., et al. Poor outcome of autologous stem cell transplantation for adult T cell leukemia/lymphoma: a case report and review of the literature. Bone Marrow Transplant 1999, 23:87-89.
3. Tsukasaki K., Utsunomiya A., Fukuda H., et al. VCAP-AMP-VECP compared with biweekly CHOP for adult T-cell leukemia-lymphoma: Japan Clinical Oncology Group Study JCOG9801. JClin Oncol 2007, 25:5458-5464.
4. Harashima N., Kurihara K., Utsunomiya A., et al. Graft-versus-Tax response in adult T-cell leukemia patients after hematopoietic stem cell transplantation. Cancer Res 2004, 64:391-399.
5. Kanda J., Hishizawa M., Utsunomiya A., et al. Impact of graft-versus-hostdisease on outcomes after allogeneic hematopoietic cell transplantation for adult T-cell leukemia: a retrospective cohort study. Blood 2012, 119:2141-2148.
6. Ishida T., Hishizawa M., Kato K., et al. Allogeneic hematopoietic stem cell transplantation for adult T-cell leukemia-lymphoma with special emphasis on preconditioning regimen: a nationwide retrospective study. Blood 2012, 120:1734-1741.
7. Itonaga H., Tsushima H., Taguchi J., et al. Treatment of relapsed adult T-cell leukemia/lymphoma after allogeneic hematopoietic stem cell transplantation: the Nagasaki Transplant Group experience. Blood 2013, 121:219-225.
8. Utsunomiya A., Miyazaki Y., Takatsuka Y., et al. Improved outcome of adult T cell leukemia/lymphoma with allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplant 2001, 27:15-20.
9. Kami M., Hamaki T., Miyakoshi S., et al. Allogeneic haematopoietic stem cell transplantation for the treatment of adult T-cell leukemia/lymphoma. Br J Haematol 2003, 120:304-309.
10. Fukushima T., Miyazaki Y., Honda S., et al. Allogeneic hematopoietic stem cell transplantation provides sustained long-term survival for patients with adult T-cell leukemia/lymphoma. Leukemia 2005, 19:829-834.
11. Nakase K., Hara M., Kozuka T., et al. Bone marrow transplantation from unrelated donors for patients with adult T-cell leukemia/lymphoma. Bone Marrow Transplant 2006, 37:41-44.
12. Kato K., Kanda Y., Eto T., et al. Allogeneic bone marrow transplantation from unrelated human T-cell leukemia virus-I-negative donors for adult T-cell leukemia/lymphoma: retrospective analysis of data from the Japan Marrow Donor Program. Biol Blood Marrow Transplant 2007, 13:90-99.
13. Shiratori S., Yasumoto A., Tanaka J., et al. Aretrospective analysis of allogeneic hematopoietic stem cell transplantation for adult T cell leukemia/lymphoma (ATL): clinical impact of graft-versus-leukemia/lymphoma effect. Biol Blood Marrow Transplant 2008, 14:817-823.
14. Yonekura K., Utsunomiya A., Takatsuka Y., et al. Graft-versus-adult T-cell leukemia/lymphoma effect following allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplant 2008, 41:1029-1035.
15. Hishizawa M., Kanda J., Utsunomiya A., et al. Transplantation of allogeneic hematopoietic stem cells for adult T-cell leukemia: a nationwide retrospective study. Blood 2010, 116:1369-1376.
16. Choi I., Tanosaki R., Uike N., et al. Long-term outcomes after hematopoietic SCT for adult T-cell leukemia/lymphoma: results of prospective trials. Bone Marrow Transplant 2011, 46:116-118.
17. Takizawa J., Aoki S., Kurasaki T., et al. Successful treatment of adult T-cell leukemia with unrelated cord blood transplantation. Am J Hematol 2007, 82:1113-1115.
18. Atsuta Y., Morishima Y., Suzuki R., et al. Comparison of unrelated cord blood transplantation and HLA-mismatched unrelated bone marrow transplantation for adults with leukemia. Biol Blood Marrow Transplant 2012, 18:780-787.
19. Atsuta Y., Suzuki R., Nagamura-Inoue T., et al. Disease-specific analyses of unrelated cord blood transplantation compared with unrelated bone marrow transplantation in adult patients with acute leukemia. Blood 2009, 113:1631-1638.
20. Nakamura T., Oku E., Nomura K., et al. Unrelated cord blood transplantation for patients with adult T-cell leukemia/lymphoma: experience at a single institute. Int J Hematol 2012, 96:657-663.
21. Fukushima T., Itonaga H., Moriuchi Y., et al. Feasibility of cord blood transplantation in chemosensitive adult T-cell leukemia/lymphoma: a retrospective analysis of the Nagasaki Transplantation Network. Int J Hematol 2013, 97:485-490.
22. Giralt S., Ballen K., Rizzo D., et al. Reduced-intensity conditioning regimen workshop: defining the dose spectrum. Report of a workshop convened by the center for international blood and marrow transplant research. Biol Blood Marrow Transplant 2009, 15:367-369.
23. Bacigalupo A., Ballen K., Rizzo D., et al. Defining the intensity of conditioning regimens: working definitions. Biol Blood Marrow Transplant 2009, 15:1628-1633.
24. Scrucca L., Santucci A., Aversa F. Competing risk analysis using R: an easy guide for clinicians. Bone Marrow Transplant 2007, 40:381-387.
25. Scrucca L., Santucci A., Aversa F. Regression modeling of competing risk using R: an in depth guide for clinicians. Bone Marrow Transplant 2010, 45:1388-1395.
26. Gooley T.A., Leisenring W., Crowley J., Storer B.E. Estimation of failure probabilities in the presence of competing risks: new representations of old estimators. Stat Med 1999, 18:695-706.
27. Cortese G., Andersen P.K. Competing risks and time-dependent covariates. Biom J 2010, 52:138-158.
28. Kanda Y. Investigation of the freely available easy-to-use software 'EZR' for medical statistics. Bone Marrow Transplant 2013, 48:452-458.
29. Laughlin M.J., Eapen M., Rubinstein P., et al. Outcomes after transplantation of cord blood or bone marrow from unrelated donors in adults with leukemia. NEngl J Med 2004, 351:2265-2275.
30. Rocha V., Labopin M., Sanz G., et al. Transplants of umbilical-cord blood or bone marrow from unrelated donors in adults with acute leukemia. NEngl J Med 2004, 351:2276-2285.
31. Sanz M.A. Cord-blood transplantation in patients with leukemia-a real alternative for adults. NEngl J Med 2004, 351:2328-2330.
32. Yamamoto K., Utsunomiya A., Tobinai K., et al. Phase I study of KW-0761, a defucosylated humanized anti-CCR4 antibody, in relapsed patients with adult T-cell leukemia-lymphoma and peripheral T-cell lymphoma. JClin Oncol 2010, 28:1591-1598.
33. Ishida T., Joh T., Uike N., et al. Defucosylated anti-CCR4 monoclonal antibody (KW-0761) for relapsed adult T-cell leukemia-lymphoma: a multicenter phase II study. JClin Oncol 2012, 30:837-842.
34. Ito Y., Miyamoto T., Chong Y., et al. Successful treatment with anti-CC chemokine receptor 4 MoAb of relapsed adult T-cell leukemia/lymphoma after umbilical cord blood transplantation. Bone Marrow Transplant 2013, 48:998-999.
35. Kato K., Miyamoto T., Numata A., et al. Diffuse panbronchiolitis after humanized anti-CCR4 monoclonal antibody therapy for relapsed adult T-cell leukemia/lymphoma. Int J Hematol 2013, 97:430-432.
36. Itonaga H., Taguchi J., Fukushima T., et al. Distinct clinical features of infectious complications in adult T cell leukemia/lymphoma patients after allogeneic hematopoietic stem cell transplantation: a retrospective analysis in the Nagasaki transplant group. Biol Blood Marrow Transplant 2013, 19:607-615.
37. de Lima M., McNiece I., Robinson S.N., et al. Cord-blood engraftment with exvivo mesenchymal-cell coculture. NEngl J Med 2012, 367:2305-2315.
38. Rocha V., Crotta A., Ruggeri A., et al. Double cord blood transplantation: extending the use of unrelated umbilical cord blood cells for patients with hematological diseases. Best Pract Res Clin Haematol 2010, 23:223-229.
39. Uchida N., Wake A., Nakano N., et al. Mycophenolate and tacrolimus for graft-versus-host disease prophylaxis for elderly after cord blood transplantation: a matched pair comparison with tacrolimus alone. Transplantation 2011, 92:366-371.